IN2009CN00831A - - Google Patents

Download PDF

Info

Publication number
IN2009CN00831A
IN2009CN00831A IN831CHN2009A IN2009CN00831A IN 2009CN00831 A IN2009CN00831 A IN 2009CN00831A IN 831CHN2009 A IN831CHN2009 A IN 831CHN2009A IN 2009CN00831 A IN2009CN00831 A IN 2009CN00831A
Authority
IN
India
Prior art keywords
amino acid
human factor
substitution
factor vii
factor viia
Prior art date
Application number
Other languages
English (en)
Inventor
Jesper Mortensen Haaning
Kim Vilbour Andersen
Claus Bornaes
Original Assignee
Maxygen Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Holdings Ltd filed Critical Maxygen Holdings Ltd
Priority claimed from PCT/DK2004/000428 external-priority patent/WO2004111242A1/en
Publication of IN2009CN00831A publication Critical patent/IN2009CN00831A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
IN831CHN2009 2004-06-18 2004-06-18 IN2009CN00831A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2004/000428 WO2004111242A1 (en) 2003-06-19 2004-06-18 FACTOR VII OR VIIa GLA DOMAIN VARIANTS

Publications (1)

Publication Number Publication Date
IN2009CN00831A true IN2009CN00831A (enExample) 2015-09-18

Family

ID=54398548

Family Applications (1)

Application Number Title Priority Date Filing Date
IN831CHN2009 IN2009CN00831A (enExample) 2004-06-18 2004-06-18

Country Status (1)

Country Link
IN (1) IN2009CN00831A (enExample)

Similar Documents

Publication Publication Date Title
IL172364A (en) Variant of vii or viia factor at gla site
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
MXPA05011522A (es) Derivados de 2-acilamino-4-feniltiazol, metodo para su preparacion y su aplicacion en terapeutica.
GB0625648D0 (en) Compounds
TW200612910A (en) Medicaments comprising carbonyl compounds, and the use thereof
BRPI0312331A2 (pt) composições de ácido hialurônico e métodos de emprego.
ITRM20050265A1 (it) Protesi modulare perfezionata per osteosintesi, in particolare per l'osteosintesi dell'omero.
TNSN08024A1 (en) 7-substituted aza-indazoles, compositions containing same, production method and use thereof
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY147767A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
ZA200800987B (en) Low pH aerated products
MXPA04002636A (es) Barra de tocador teniendo un acidificador latente.
IL172773A (en) Formulations for the treatment of arthritis conditions
TW200630367A (en) Substituted adenines and the uses thereof
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
TW200724140A (en) Hydantoin compounds
MX2007001953A (es) Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
MY147790A (en) Stable emulsion composition
BRPI0408446A (pt) tablete de limpeza
MX2007011327A (es) Empleo de 5'-metiltioadenosina (mta) en la prevencion y/o tratamiento de enfermedades autoinmunes y/o rechazo de transplantes.
IN2009CN00831A (enExample)
MXPA05012605A (es) Composiciones que comprenden compuestos de gastrina y sus usos en la diabetes.
GB2434795A (en) Pyrrolo [2, 1-C] [1, 4] benzodiazepine-anthraquinone conjugates useful as antitumour agents
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors